arrow
L

Lidia Rudnicka

Medical University of Warsaw
H指数:58
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction: Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program

更正:来自ALLEGRO临床试验方案的口服JAK3/TEC家族激酶抑制剂利特昔替尼治疗斑秃的综合安全性分析

2026-09-250
OAAI
Phototype-related Trichoscopic differences in lichen Planopilaris and frontal Fibrosing alopecia

光型相关的镜下差异在扁平苔藓和前额纤维性脱发中的应用

2026-07-290
PRE
Localized lichen planopilaris without patches: a multicenter retrospective study of 74-patients

局限性扁平苔藓样毛囊炎无斑块:一项74例患者的多中心回顾性研究

2026-06-010
OAAI
Trichoscopy of Cicatricial Alopecia in Fair and Dark Skin: A Multicenter International Study of the EADV Task Force on Hair Diseases and the IDS Task Force on Trichoscopy

瘢痕性脱发在肤色较浅和肤色较深人群中的毛发镜检查:欧洲皮肤与性病学会联盟毛发疾病工作组与印度皮肤科协会毛发镜检查工作组的跨国多中心研究

2026-05-010
PRE
Management of classic lichen planopilaris: The EADV task force on hair diseases position statement

经典扁平苔藓的管理:欧洲皮肤与 венерические болезни 学会头发疾病工作组立场声明

2026-03-180
PRE
Global registry of alopecia areata disease severity and treatment safety: findings from an international pilot and optimization of a scalable real-world registry

全球斑秃疾病严重程度和治疗安全性的登记注册:一项国际试点研究的发现及可扩展真实世界登记注册的优化

2026-01-010
OAAI
Gut Microbiota Influence Host Metabolism and Immune Responses in Atopic Dermatitis : A Next-Generation Sequencing-Based Functional Profiling Study

Blicharz, L.; Bukowska-Ośko, I.; Perlejewski, K.; Navarro-López, V.; Czuwara, J.; Waśkiel-Burnat, A.; Samochocki, Z.; Olszewska, M.; Rudnicka, L.; Radkowski, M. 肠道微生物组影响特应性皮炎宿主代谢和免疫反应:一项基于下一代测序的功能分析研究。Clin. Cosmet. Investig. Dermatol. 2026, 19, 1–15. [Google Scholar] [CrossRef] [PubMed]

2026-01-011
PRE
Beyond the surface: Histopathologic inflammation persists in many patients with clinically quiescent primary cicatricial alopecia

超越表面:在临床上静止的原发性瘢痕性脱发患者中,组织病理学炎症持续存在。

2025-11-180
PRE
362 Efficacy, Safety, and Tolerability of Upadacitinib in Adults and Adolescents With Severe Alopecia Areata: Results From the Randomized, Placebo-Controlled, Double-Blind Phase 3 Program (UP-AA)

362 乌帕替尼在成人和青少年重度斑秃患者中的疗效、安全性和耐受性:来自随机、安慰剂对照、双盲III期研究(UP-AA)的结果

2025-11-100
PRE
Alopecia areata

斑秃

2025-11-060
PRE
Quality of life, psychosocial difficulties and bullying in paediatric patients with alopecia areata: a European cross-sectional study

生活质量、心理社会困难及欺凌在儿童斑秃患者中的表现:一项欧洲横断面研究

2025-10-012
OAAI
Correction to: Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program

更正:来自ALLEGRO临床研究项目的口服JAK3/TEC家族激酶抑制剂Ritlecitinib治疗斑秃的综合安全性分析

2025-09-110
OAAI